OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
London, UK-September 3, 2009
Chiltern International Limited, a global clinical research organization (CRO) has been selected as the sole provider of clinical research staff for the monitoring aspect of all clinical research projects for Western Europe for a top pharmaceutical company.
All CRAs will be seconded via Chiltern’s European Resourcing Solutions team and fully allocated to the company under a Functional Service or FSP model. The Chiltern CRAs will work directly with the client Project Managers.
Another leading pharmaceutical company also selected Chiltern as the sole provider of an FSP relationship within their pharmacovigilance team. FSP relationships are gaining popularity in the industry due to the flexibility in resource allocations and the cost savings they can offer to clients.
“These are great achievements for Chiltern,” commented Linda Christmas, Chiltern Executive Vice President, Resourcing Solutions, “and helps us meet our target to develop strategically aligned relationships with our clients. We are delighted that we have been able to partner with two more leading pharmaceutical companies in two different core functions.”